Solid Tumor Advances: T-Cell Engagers, Radioligands, and More
February 11, 2025
Oncology remains one of the top therapeutic areas garnering investor interest, and scientific advances are yielding new approaches that are showing sometimes game-changing clinical promise in treating solid tumors. This session will discuss the promising modalities that are captivating investors and physicians alike.
)
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}